Cohausz & Florack has added two new partners to the team to further expand the firm’s IP expertise in key technical areas.
Leader of Brown Rudnik’s IP practice moves to US office of London firm | Boston office continues growth.
Two rivals withdrew from acquisition process| Agreement provides access to blockbuster medicines | Janssen Global Services | Sanofi.
Arbitration panel awarded the sum to Acorda to cover past royalties and interest | Acorda can now source the multiple sclerosis drug elsewhere.
Dispute against LabCorp claims wilful infringement | Plaintiff has also sued Illumina, Roche and Myriad in separate cases.
New partner specialises in chemical-related tech | USPTO-registered litigator is also certified licensing professional | Appointment follows several hires in firm’s patents department.
The lawsuit centres on patented molecular instruments | The patents-in-suit cover cover features of RNAscope tech.
Evidence shows medicines approved as biosimilars in the EU may be prescribed interchangeably | Additional ‘switch’ studies no longer not need to be carried out.
Kansas-based company wins block on infringing plant-based albumins | Genetically programmed rice expresses human proteins used in immunotherapy drugs, gene therapies and vaccines.
Japan-based pharma company must pay for infringment | Drug was recently approved for breast cancer treatment by EU.